tiprankstipranks

FRANK ZAVRL Insider Profile

4 Followers
FRANK ZAVRL, Director at Puma Biotechnology, holds 960.07K shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in CervoMed (Ticker: CRVO).
tipranks
FRANK ZAVRL

FRANK ZAVRL
Puma Biotechnology (PBYI)
Director

Not Ranked
FRANK ZAVRL has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
0.00%
A breakdown of FRANK ZAVRL's holdings

Insider Roles

Puma Biotechnology
(PBYI)
Director
CervoMed
(CRVO)
Director
Roles that FRANK ZAVRL holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by FRANK ZAVRL

FRANK ZAVRL's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Puma Biotechnology
Jun 11, 2020
Director
Uninformative Buy
$4.64M
CervoMed
Director
List of latest transactions for each holding click on a transaction to see FRANK ZAVRL's performance on stock

FRANK ZAVRL insider profile FAQ

What is the percentage of profitable transactions made by FRANK ZAVRL?
The percentage of profitable transactions made by FRANK ZAVRL is ―.
    What is the average return per transaction made by FRANK ZAVRL?
    The average return per transaction made by FRANK ZAVRL is ―.
      What stocks does FRANK ZAVRL hold?
      FRANK ZAVRL holds: PBYI, CRVO stocks.
        What was FRANK ZAVRL’s latest transaction?
        FRANK ZAVRL latest transaction was an Uninformative Buy of ―.
          What was FRANK ZAVRL's most profitable transaction?
          FRANK ZAVRL’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is FRANK ZAVRL's role in Puma Biotechnology?
            FRANK ZAVRL's role in Puma Biotechnology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.